PATENT CLAIM ANALYSIS

Application Number: 16040012
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "294000"]

Abstract:
Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.

Claim (Index 4):
The method of  claim 3 , wherein the improvement is measured from a pre-treatment, baseline to maintenance therapy.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 95.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14900028', '11355339', '12638227', '14307195', '11340802']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7248835892528056
- 35 USC 102 Novelty (BERT): 0.5245811878335764
- Combined Prediction Score: 0.7048533491108827
- Mean Citation Score: 254.932838
- Max Citation Score: 300.44366
- Similarity Product: 208.8543467859292

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test